Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

Volume:8   Issue:5
Pp: 342-348
D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi
DOI: 10.2174/156800908785133204

Targeting Angiogenesis in Renal Cell Carcinoma

Volume:8   Issue:5
Pp: 349-358
Georgios Lainakis and Aristotle Bamias
DOI: 10.2174/156800908785133132

Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy

Volume:8   Issue:5
Pp: 359-366
C. Braconi, R. Bracci and R. Cellerino
DOI: 10.2174/156800908785133169

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer

Volume:8   Issue:5
Pp: 367-377
George G. Chen, Alexander C. Vlantis, Qiang Zeng and C. Andrew van Hasselt
DOI: 10.2174/156800908785133150

Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer

Volume:8   Issue:5
Pp: 392-403
Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome
DOI: 10.2174/156800908785133187

Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy

Volume:8   Issue:5
Pp: 414-420
A. Gradilone, F. M. Pulcinelli, L. V. Lotti, E. Trifiro, S. Martino, O. Gandini, W. Gianni, L. Frati, A. M. Agliano and P. Gazzaniga
DOI: 10.2174/156800908785133178

NUPR1 Interacts with p53, Transcriptionally Regulates p21 and Rescues Breast Epithelial Cells from Doxorubicin-Induced Genotoxic Stress

Volume:8   Issue:5
Pp: 421-430
David W. Clark, Aparna Mitra, Rebecca A. Fillmore, Wen G. Jiang, Rajeev S. Samant, Oystein Fodstad and Lalita A. Shevde
DOI: 10.2174/156800908785133196